Sichuan Hebang Biotechnology Co Ltd Working Capital to Net Assets Ratio
Sichuan Hebang Biotechnology Co Ltd working capital to net assets ratio. Sichuan Hebang Biotechnology Co Ltd (603077) has a Working Capital to Net Assets ratio of 54.1% as of June 2026. Working capital of CN¥10.47 Billion (current assets of CN¥13.14 Billion minus current liabilities of CN¥2.67 Billion) is measured against net assets of CN¥19.34 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Working capital to net assets ratio of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. This chart shows how Sichuan Hebang Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of June 2026, the ratio stands at 54.1%, reflecting working capital of CN¥10.47 Billion against net assets of CN¥19.34 Billion CNY. Explore long-term investment intensity of Sichuan Hebang Biotechnology Co Ltd to see how much of total assets are deployed in long-term investments.
Sichuan Hebang Biotechnology Co Ltd Working Capital to Net Assets Ratio by Year (2009–2025)
Sichuan Hebang Biotechnology Co Ltd working capital to net assets ratio by year from 2009 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Sichuan Hebang Biotechnology Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.9% | CN¥8.24 Billion | CN¥17.96 Billion | CN¥12.02 Billion | CN¥3.78 Billion | ▲ +0.5 pp |
| 2024 | 45.4% | CN¥8.63 Billion | CN¥19.01 Billion | CN¥14.00 Billion | CN¥5.37 Billion | ▲ +14.8 pp |
| 2023 | 30.6% | CN¥6.18 Billion | CN¥20.22 Billion | CN¥9.85 Billion | CN¥3.67 Billion | ▲ +0.3 pp |
| 2022 | 30.3% | CN¥5.98 Billion | CN¥19.76 Billion | CN¥9.72 Billion | CN¥3.73 Billion | ▲ +19.9 pp |
| 2021 | 10.4% | CN¥1.52 Billion | CN¥14.64 Billion | CN¥4.64 Billion | CN¥3.12 Billion | ▲ +8.9 pp |
| 2020 | 1.5% | CN¥165.62 Million | CN¥11.31 Billion | CN¥3.32 Billion | CN¥3.15 Billion | ▼ -4.7 pp |
| 2019 | 6.2% | CN¥706.80 Million | CN¥11.45 Billion | CN¥3.49 Billion | CN¥2.78 Billion | ▼ -9.5 pp |
| 2018 | 15.7% | CN¥1.75 Billion | CN¥11.20 Billion | CN¥3.51 Billion | CN¥1.76 Billion | ▼ -4.4 pp |
| 2017 | 20.1% | CN¥2.26 Billion | CN¥11.27 Billion | CN¥3.58 Billion | CN¥1.32 Billion | ▼ -1.1 pp |
| 2016 | 21.1% | CN¥2.28 Billion | CN¥10.78 Billion | CN¥3.61 Billion | CN¥1.33 Billion | ▲ +42.1 pp |
| 2015 | -20.9% | CN¥-1.38 Billion | CN¥6.58 Billion | CN¥2.34 Billion | CN¥3.72 Billion | ▲ +12.1 pp |
| 2014 | -33.0% | CN¥-1.57 Billion | CN¥4.75 Billion | CN¥1.78 Billion | CN¥3.35 Billion | ▼ -52.7 pp |
| 2013 | 19.7% | CN¥647.89 Million | CN¥3.29 Billion | CN¥2.13 Billion | CN¥1.49 Billion | ▼ -23.1 pp |
| 2012 | 42.8% | CN¥1.46 Billion | CN¥3.40 Billion | CN¥2.35 Billion | CN¥895.98 Million | ▲ +57.4 pp |
| 2011 | -14.6% | CN¥-195.47 Million | CN¥1.34 Billion | CN¥922.83 Million | CN¥1.12 Billion | ▲ +28.2 pp |
| 2010 | -42.8% | CN¥-417.04 Million | CN¥974.62 Million | CN¥727.15 Million | CN¥1.14 Billion | ▲ +34.2 pp |
| 2009 | -77.0% | CN¥-567.90 Million | CN¥737.62 Million | CN¥726.64 Million | CN¥1.29 Billion | — |